PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31239273-7 2019 Targeting SPHK1 and NFkappaB using clinically applicable inhibitors (safingol and bortezomib, respectively) significantly inhibited aggressive mammary tumor growth and spontaneous lung metastasis in orthotopic syngeneic TNBC mouse models. safingol 69-77 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus 20-28